Back to results
US 2021/0261673 A1Published application
Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor Antibody
AssigneeFresenius Kabi Deutschland GmbH
InventorsAlessandra DEL RIO, Carmela SABINA
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel protein formulation. In particular, the invention relates to a liquid pharmaceutical composition of an antibody directed to Interleukin-6 receptor, a method of manufacturing the composition, a kit including the composition, a package including the composition and to methods of treatment using the composition and/or package.
Claims11
A liquid pharmaceutical composition comprising:
- (a) an anti-IL-6 receptor (anti-IL-6R) antibody;
- (b) an histidine buffer;
- (c) a polyol;
- (d) a free amino acid;
- (e) a surfactant;
- (f) water for injection;
- and
- (g) optionally a salt.
- wherein the composition has a pH between 5.5 and 7.5.
6 more elements
Dependencies are inferred from the claim text.